← Back to Search

Hand Acupuncture for Pain

N/A
Waitlist Available
Research Sponsored by Washington University School of Medicine
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Pain >=4 on Numeric Pain Rating Scale with one of predetermined motions.
Primary pain localized to neck, shoulder, low back, hip.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up pre-acupuncture, 1 week post-acupuncture, 2 weeks post-acupuncture, 4 weeks post-acupuncture, 8 weeks post-acupuncture

Summary

This trial is testing whether acupuncture works for pain in the neck, shoulder, low back, or hip that is worse when movement is involved. It is also testing whether movement during the acupuncture treatment helps.

Who is the study for?
This trial is for individuals with primary pain in the neck, shoulder, low back, or hip rated at least 4 on a pain scale during certain movements. Participants must be willing to engage in the study and complete questionnaires.
What is being tested?
The study tests one needle hand acupuncture's effectiveness for treating musculoskeletal disorders. It compares three methods: control acupuncture with movement, one needle without movement, and one needle with movement over time.
What are the potential side effects?
While not specified here, common side effects of acupuncture may include slight bleeding or bruising at the needle site, soreness or minor pain where needles are inserted.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
My pain level is 4 or higher when I move in certain ways.
Select...
My main pain is in my neck, shoulder, lower back, or hip.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~pre-acupuncture, post-acupuncture + 10 minutes
This trial's timeline: 3 weeks for screening, Varies for treatment, and pre-acupuncture, post-acupuncture + 10 minutes for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in Numeric Pain Rating Scale (NPRS)
Percentage Change in Pain
Secondary study objectives
Change in Total Arc of Motion
Other study objectives
Change in Patient-Reported Outcome Measurement Information Systems (PROMIS)
Change in RAND 12 score
Presence of Deqi response
+2 more

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Placebo Group
Group I: Verum Acupuncture with MovementExperimental Treatment1 Intervention
Verum acupuncture along radial side of 2nd metacarpal, following by active movement of previously painful body part x 10 minutes.
Group II: Verum Acupuncture without MovementActive Control1 Intervention
Verum acupuncture along radial side of 2nd metacarpal, following by laying on examination table x 10 minutes.
Group III: Control Acupuncture with MovementPlacebo Group1 Intervention
Sham/control acupuncture at acupoint LI4, following by active movement of previously painful body part x 10 minutes.

Find a Location

Who is running the clinical trial?

Washington University School of MedicineLead Sponsor
2,000 Previous Clinical Trials
2,344,142 Total Patients Enrolled
Tonia ThompsonStudy DirectorWashington University School of Medicine

Media Library

One Needle Hand Acupuncture with Movement Clinical Trial Eligibility Overview. Trial Name: NCT04048941 — N/A
Range of Motion Research Study Groups: Verum Acupuncture without Movement, Verum Acupuncture with Movement, Control Acupuncture with Movement
Range of Motion Clinical Trial 2023: One Needle Hand Acupuncture with Movement Highlights & Side Effects. Trial Name: NCT04048941 — N/A
One Needle Hand Acupuncture with Movement 2023 Treatment Timeline for Medical Study. Trial Name: NCT04048941 — N/A
~19 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top